Publications by authors named "Annebel de Gier"
An increased total stent length (TSL) might be associated with a higher risk of clinical events; however, in patients with multivessel disease (MVD), a considerable TSL is often required. In patients presenting with acute coronary syndrome and MVD, immediate complete revascularization was associated with shorter TSL in the BIOVASC (Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease) Trial. This is a subanalysis of the BIOVASC trial comparing clinical outcomes in patients with either <60 or ≥60 mm TSL.
View Article and Find Full Text PDFArticle Synopsis
- Complete revascularization (CR) in patients with acute coronary syndromes (ACS) and multivessel disease (MVD) leads to better clinical outcomes than treating only the "culprit" artery, but the best timing for treating additional arteries remains uncertain.
- This study analyzed 1,400 ACS patients with MVD at Erasmus University Medical Center from 2015 to 2021, comparing immediate versus staged CR treatments in terms of major adverse cardiac and cerebrovascular events (MACCEs).
- Results showed that patients who underwent staged CR had a significantly higher MACCE rate and used more stents and contrast compared to those who received immediate CR, suggesting that immediate treatment may be safer and more efficient.